Leaderboards/Osteomyelitis and Bone Disorders Research

Osteomyelitis and Bone Disorders Research

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
David E. Place
St. Jude Children's Research Hospital
2
Yoann Conan
Université de Tours
3
Tetsuya Yoshimoto
Hiroshima University Hospital
4
Yongmei Ge
Xinjiang Production and Construction Corps
5
Ashna IE Ramautar
Leiden University Medical Center
6
D. Sai Krishna
JSS Dental College and Hospital
7
Kristin Happ Molitoris
Duke University
8
Anja Schnabel
Technische Universität Dresden
9
Susanne Baertl
University Hospital Regensburg
10
Nashwah G. M. Attallah
National Organization for Drug Control and Research

Rising Stars Papers

1
Osteoimmunology of Fracture Healing
Current Osteoporosis Reports|2024
52 cit.
2
The impact of age and sex on the inflammatory response during bone fracture healing
JBMR Plus|2024
21 cit.
3
Peek@ZIF-8(CEL) as a Novel Bone Implant for Large Defect Repair and Enhanced Bone Healing via a Long-Term Stable Bioactive Releaser
ACS Applied Materials & Interfaces|2024
11 cit.
4
The PJI-TNM classification for periprosthetic joint infections
Bone and Joint Research|2024
7 cit.
5
Defining the imaging diagnostic criteria for adult chronic non-bacterial osteitis
JBMR Plus|2024
4 cit.
6
Polyostotic fibrous dysplasia in an adult with middle ear cholesteatoma and ipsilateral visual impairment
Brain Disorders|2025
1 cit.
7
Abstract 4366197: Selnoflast reduces markers of systemic inflammation in participants with coronary artery disease and elevated C-reactive protein
Circulation|2025
1 cit.
8
Comparability of Two Anti-phospholipase A2 Receptor (PLA2R) Enzyme-Linked Immunosorbent Assays (ELISAs) in Patients with Primary Membranous Nephropathy
Journal of the American Society of Nephrology|2024
0 cit.
9
Réforme du 3e cycle et DES de Maladies Infectieuses et Tropicales : quel bilan? Une enquête transversale nationale.
Médecine et Maladies Infectieuses Formation|2025
0 cit.
10
Identification of MMD2 as a Novel Causative Gene for Aggressive Periodontitis and Functional Analysis of Its Pathogenic Role
Journal of Human Immunity|2026
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Rodolfo Mauceri
Ospedale degli Infermi
2
Nele Herregods
Alberta Hospital Edmonton
3
Weixin Hao
Chinese Academy of Medical Sciences & Peking Union Medical College
4
Hong‐Hee Kim
Seoul National University
5
Thomas Lehmann
Federal Roads Office
6
Elizabeth M. Winter
Leiden University Medical Center
7
Janine M. Preble
Kresge Eye Institute
8
Wen Zhang
Shanghai Children's Medical Center
9
Suzanne C. Li
Hackensack Meridian Health
10
Melissa Oliver
Riley Hospital for Children

Emerging Leaders Papers

1
The multi-faceted nature of age-associated osteoporosis
Bone Reports|2024
50 cit.
2
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting
Bone|2022
29 cit.
3
MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series
BMC Oral Health|2023
28 cit.
4
Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study
JBMR Plus|2022
23 cit.
5
Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO)
Orphanet Journal of Rare Diseases|2023
22 cit.
6
MRI-based synthetic CT for assessment of the bony elements of the sacroiliac joints in children
Insights into Imaging|2024
22 cit.
7
The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland
Osteoporosis International|2024
22 cit.
8
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
Osteoporosis International|2023
18 cit.
9
Time-scale analysis of the long-term variability of human gut microbiota characteristics in Chinese individuals
Communications Biology|2022
13 cit.
10
Apparent diffusion coefficient values of the white matter in magnetic resonance imaging of the neonatal brain may help predict outcome in congenital cytomegalovirus infection
Pediatric Radiology|2024
12 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Christian M. Hedrich
University of Liverpool
2
Steven L. Teitelbaum
Washington University in St. Louis
3
Thirumala‐Devi Kanneganti
St. Jude Children's Research Hospital
4
Polly J. Ferguson
University of Iowa
5
Stuart H. Ralston
Western General Hospital
6
Ajay Goel
City of Hope
7
Ronald M. Laxer
Hospital for Sick Children
8
Sankar Ghosh
Columbia University Irving Medical Center
9
Athimalaipet V Ramanan
University of Bristol
10
Francesco Trotta
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari

Current Senior Leaders Papers

1
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Science|1994
1.8k cit.
2
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Cell|2020
1.7k cit.
3
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS
Nature|2011
1.6k cit.
4
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
Journal of Clinical Investigation|2000
1.4k cit.
5
Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300
Molecular Cell|1998
1.2k cit.
6
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"
Nature|1990
1.2k cit.
7
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
Nature|2006
1.1k cit.
8
A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria
Science|2004
1k cit.
9
The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
Immunity|2010
976 cit.
10
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Molecular Cell|2002
940 cit.

Reagents for Osteomyelitis and Bone Disorders Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Non-phospho (Active) beta-Catenin (Ser33/37/Thr41) (D13A1) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#41334$493
View Evidence →
Cell Signaling TechnologyEvidence 64

p38 alpha MAPK (7D6) Rabbit Monoclonal Antibody

#2371$158,348
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

GKAP Antibody

#13602$317
View Evidence →
Cell Signaling Technology

15-PGDH/HPGD (E9H7W) Rabbit Monoclonal Antibody (BSA and Azide Free)

#63108$865
View Evidence →
Cell Signaling TechnologyEvidence 60

Phospho-c-Raf (Ser289/296/301) Antibody

#9431$150,863
View Evidence →